Work

Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy

Year: 2026

Type: article

Study design: Case Report

Source: New England Journal of Medicine

DOI: 10.1056/nejmc2605958

Authors: David Steffin, Amy N. Courtney, Michelle Choe, Nisha Ghatwai, Magdalena A. Esparza Cerda, Ramy Sweidan, Rajdekar Dhanashree, Huimin Zhang, Natasha Lapteva, Zhuyong Mei, Bambi J. Grilley, Leonid S. Metelitsa, Helen E. Heslop, Malcolm K. Brenner, Andras Heczey

Institutions: Baylor College of Medicine, Fred Hutch Cancer Center, Texas Children's Hospital, Houston Methodist, Seattle Children's Hospital

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Prevention and Research Institute of Texas, National Institutes of Health

Awards: G4371405054, Renewal of CPRIT GMP Core, G9000036102, G9000270981

OpenAlex ID: W7212062894

FWCI:

Cites: 5

Cited by:

Related to: